CELLCENTRIC LIMITEDActive
Key figures
CELLCENTRIC LIMITED does not disclose its turnover in its latest accounts; the profit for the year is as stated in the accounts.
Ratios
2023Balance sheet structure
Filed accounts2020–2023
| 2020 | 2021 | 2022 | 2023 | |
|---|---|---|---|---|
| Profit for the year | — | -9,281,892 | -12,021,282 | -11,492,956 |
| Cash at bank and in hand | 15,643,699 | 22,137,191 | 11,163,779 | 23,933,758 |
| Total assets | 16,242,160 | — | 12,046,863 | 25,429,519 |
| Total liabilities | 780,998 | — | 2,137,837 | 24,657,368 |
| Net assets / total equity | 15,461,162 | 21,228,544 | 9,909,026 | 772,151 |
| Average number of employees | 10 | 13 | 18 | 20 |
A dash (—) means no accounts were filed for that year or the item is not in the accounts; 0 is a zero stated in the accounts. Small companies usually file only a balance sheet, so the profit and loss account is often missing.
Summary: CELLCENTRIC LIMITED
Company
CELLCENTRIC LIMITED is a private limited company registered with Companies House under company number 04948632. It was incorporated on 30 Oct 2003. Its status is active. The registered office is in Cambridge (CB10). Its nature of business (SIC 2007) is research and experimental development on biotechnology (72110).
Accounts
The latest accounts in the database are for 2023 (period ending 31 Dec 2023); the company files small company accounts. Loss for the year was £11,492,956. Net assets were £772,151, down 92.2% on the previous year. Cash at bank and in hand was £23,933,758. Total assets were £25,429,519 and total liabilities £24,657,368. The company had an average of 20 employees. Figures are available for 4 financial years (2020–2023).
Control and charges
2 persons with significant control are registered.
Filing deadlines
The next accounts are due by 30 Sep 2026. The next confirmation statement is due by 27 May 2027.